laronidase

Ukraine

Drugs containing this active substance

  • ALDURAZYME®

    The drug is intended for long-term enzyme replacement therapy in patients with mucopolysaccharidosis type I (MPS I). It is used to treat manifestations of the disease that are not related to nervous system involvement.

    Form: concentrate for infusion solution

    Active substance Dosage
    laronidase 100 IU/ml

    ATC: A16AB05

    Manufacturer: Wetter Pharma-Fertigung GmbH & Co. KG (final filling of vials (primary packaging), performing sterility testing)